Investors in Seattle know what they own. So do not waste time and effort here spewing BS. This type of washouts have been typical for this company and have always been followed by quick ascends to new highs after the traders take their profits and volume dries up. After several years of trials and over one year on the market, if there was above normal tendency for pancreatitis it would have shown by now. If you had taken the time to informing yourself, you would have known that the rate of pancreatitis is 1 per 600 patients which is as low or lower than it is for all cancer treatments. After all they all are poisons and as such they cause collateral damage and complications (that is why people get sick when treated) however risk and suffering are vastly more acceptable than the alternative. Hang around and you may learn something.